- Home
- PHAR vs TGB Comparison
PHAR vs TGB Comparison
Compare PHAR & TGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PHAR | TGB |
|---|---|---|
| Founded | 1988 | 1966 |
| Country | Netherlands | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 2.0B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PHAR | TGB |
|---|---|---|
| Price | $17.16 | $6.10 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $38.00 | $5.00 |
| AVG Volume (30 Days) | 27.7K | ★ 6.1M |
| Earning Date | 11-06-2025 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.00 | N/A |
| Revenue | $362,274,000.00 | ★ $428,559,326.00 |
| Revenue This Year | $25.19 | $10.35 |
| Revenue Next Year | $4.47 | $61.39 |
| P/E Ratio | $2,989.65 | ★ N/A |
| Revenue Growth | ★ 26.78 | 0.50 |
| 52 Week Low | $7.50 | $1.67 |
| 52 Week High | $18.30 | $6.32 |
Technical Indicators
Market Signals| Indicator | PHAR | TGB |
|---|---|---|
| Relative Strength Index (RSI) | 51.86 | 68.90 |
| Support Level | $16.55 | $5.49 |
| Resistance Level | $17.37 | $6.32 |
| Average True Range (ATR) | 0.68 | 0.23 |
| MACD | -0.09 | 0.03 |
| Stochastic Oscillator | 45.68 | 80.33 |
Price Performance
Historical ComparisonAbout PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About TGB Taseko Mines Ltd.
Taseko Mines Ltd is a Canadian mining company. It is principally engaged in the production and sale of metals, as well as related activities, including exploration and mine development, within the province of British Columbia, Canada, and the State of Arizona, the United States. The Gibraltar, Aley, New Prosperity, Yellowhead properties are located in British Columbia whereas Florence copper is in central Arizona.